Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yoshino Matsuo

Addition of a Nitric Oxide Donor to an Angiotensin II Type 1 Receptor Blocker May Cancel Its Blood Pressure-Lowering Effects

International Heart Journal
MedicineCardiovascular MedicineCardiology
2015English

Ezetimibe Monotherapy Reduces Serum Levels of Platelet-Activating Factor Acetylhydrolase in Patients With Dyslipidemia

Journal of Clinical Medicine Research
2019English

Related publications

Angiotensin Receptor Blocker Protection Against Podocyte-Induced Sclerosis Is Podocyte Angiotensin II Type 1 Receptor-Independent

Hypertension
Internal Medicine
2010English

Pharmacological Interventions Into the Renin–angiotensin System With ACE Inhibitors and Angiotensin II Receptor Antagonists: Effects Beyond Blood Pressure Lowering

Therapeutic Advances in Cardiovascular Disease
Cardiovascular MedicinePharmacologyCardiology
2016English

Summertime Dosage-Dependent Hypersensitivity to an Angiotensin II Receptor Blocker

2014English

Summertime Dosage-Dependent Hypersensitivity to an Angiotensin II Receptor Blocker

2015English

Suppression of Experimental Autoimmune Uveitis by Angiotensin II Type 1 Receptor Blocker Telmisartan

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2009English

Age-Related Difference in the Sleep Pressure-Lowering Effect Between an Angiotensin II Receptor Blocker and a Calcium Channel Blocker in Asian Hypertensives: The ACS1 Study

Hypertension
Internal Medicine
2015English

Renoprotective Effects of Benidipine in Combination With Angiotensin II Type 1 Receptor Blocker in Hypertensive Dahl Rats

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2003English

Adenosine A1-Receptor Deficiency Diminishes Afferent Arteriolar and Blood Pressure Responses During Nitric Oxide Inhibition and Angiotensin II Treatment

American Journal of Physiology - Regulatory Integrative and Comparative Physiology
Physiology
2011English

Effects of YM358, an Angiotensin II Type 1(AT1) Receptor Antagonist, and Enalapril on Blood Pressure and Vasoconstriction in Two Renal Hypertension Models.

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy